8-K/A: Spyre Therapeutics Corrects Filing Date in Amended 8-K Report
8-K Amendment
Spyre Therapeutics has filed an amended 8-K report to correct a clerical error regarding the date of the original filing, which was August 7, 2024.
Summary
- Spyre Therapeutics filed an amended 8-K report to correct a clerical error.
- The original 8-K report, concerning the company's financial results for the quarter ended June 30, 2024, was filed on August 7, 2024.
- The amendment solely corrects the date of report on the cover page of the original 8-K.
- No other information in the original filing or its exhibits has been modified or updated.
Sentiment
Score: 7
Explanation: The document is a routine correction of a clerical error, which is a neutral event. The promptness of the correction is slightly positive.
Positives
- The company has promptly corrected a clerical error in its filing.
Stakeholder Impact
- The correction ensures accurate information is available to stakeholders.
Key Dates
| Date | Description |
|---|---|
| August 7, 2024 | Date of the original 8-K filing and the amended 8-K/A filing. |
Keywords
8-K, amendment, filing, clerical error, financial results, Spyre Therapeutics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.